共 23 条
[1]
Lewis W., Day B.J., Copeland W.C., Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective, Nat. Rev. Drug Discov., 2, pp. 812-822, (2003)
[2]
Lewis W., Copeland W.C., Day B.J., DNA depletion, oxidative stress and mutation: Mechanisms of dysfunction from NRTIs, Lab. Invest., 81, pp. 777-790, (1998)
[3]
Staal E.J., Glutathione and HIV infection: Reduced reduced, or increased oxidized?, Eur. J. Clin. Invest., 28, pp. 194-196, (1998)
[4]
Aukrust P., Muller F., Svardal A.M., Ueland T., Berge R.K., Froland S.S., Disturbed glutathione metabolism and decreased antioxidant levels in HIV-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants, J. Infect. Dis., 188, pp. 232-238, (2003)
[5]
De La Asunciion J.G., Del Olmo M.L., Sastre J., Pallardo F.V., Vina J., AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins, J. Clin. Invest., 102, pp. 4-9, (1998)
[6]
Papadopulos-Eleopulos E., Turner V.F., Papadimitriou J.M., Causer D., Alphonso H., Miller T., A critical analysis of the pharmacology of AZT and its use in AIDS, Curr. Med. Res. Opin., 15, (1999)
[7]
Barry M.G., Khoo S.H., Veal G.J., Et al., The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites, AIDS, 10, pp. 1361-1367, (1996)
[8]
Veal G.J., Back D.J., Metabolism of zidovudine, Gen. Pharmacol., 26, pp. 1469-1475, (1995)
[9]
Mak I.T., Murphy A.M., Hopper A., Witiak D., Ziemniak J., Weglicki W.B., Potent inhibitory activities of hydrophobic aci-reductones against membrane and human LDL oxidation, Biochem. Pharmacol., 55, pp. 1921-1926, (1998)
[10]
Mak I.T., Zhang J., Weglicki W.B., Cytoprotective properties of nisoldipine and amlodipine against oxidative endothelial cell injury, Ann. NY Acad. Sci., 899, pp. 399-402, (2000)